IFNG and neoplasm: 2DG as a glycolysis inhibitor could also suppress anti-tumor T cell responses as glycolysis supports the fast proliferation of activated T cells [44,45] and is crucial for several effector functions, particularly the secretion of interferon gamma (IFN-γ) [46,47,48,49].